Oncotype DX Breast Recurrence Score® Test Welcome Kit Download

Oncotype DX Breast Recurrence Score^® Test

We recognize every patient journey is unique, and we are here to provide resources that empower both you and your patients to make more informed decisions on their therapeutic selection. Resources include:

NCCN breast cancer guidelines
Key insights from the TAILORx and RxPONDER studies
Patient education brochures for your office
Annotated sample reports
Introduction to our precision oncology portfolio
Helpful guide to the Exact Sciences Provider Ordering Hub

The Oncotype DX Breast Recurrence Score Test welcome kit sitting on a table.

Request your welcome kit now

Please complete the form below. All fields are required, unless noted as optional.

Footnotes

Oncotype DX, Oncotype DX Breast Recurrence Score, Breast Recurrence Score, and Recurrence Score are registered trademarks of Genomic Health, Inc., a wholly-owned subsidiary of Exact Sciences Corporation. Exact Sciences is a registered trademark of Exact Sciences Corporation. All other trademarks are the properties of their respective owners.

The Oncotype DX Breast Recurrence Score test was developed, and the performance characteristics validated by Genomic Health, Inc., a wholly-owned subsidiary of Exact Sciences Corporation following College of American Pathologists (CAP) and Clinical Laboratory Improvement Amendments (CLIA) regulations. The Oncotype DX Breast Recurrence Score test is performed at the Genomic Health Redwood City clinical laboratory. Exact Sciences clinical laboratories are accredited by CAP, certified under CLIA regulations, and qualified to perform high-complexity clinical laboratory testing. This test has not been cleared or approved by the US Food and Drug Administration or other notified regulatory authority.

Request your welcome kit today

Request your welcome kit now

Footnotes